Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
BMC Cancer
; 12: 292, 2012 Jul 17.
Article
in En
| MEDLINE
| ID: mdl-22804917
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Proto-Oncogene Proteins
/
Ras Proteins
/
MicroRNAs
/
DNA Copy Number Variations
/
Mutation
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2012
Type:
Article
Affiliation country:
Netherlands